Development and Reform Commission: high value consumables ex-factory price open, packing control price!

October 22, the National Development and Reform Commission issued the 18th issue since the medical price reform report, which proposed in the current and future period, will focus on four aspects to strengthen the high value of medical supplies price regulation.

Made four strokes are all 'real hammer', more once encountered enterprise Boycott, long-term shelved policy or will come back.

The report said: has been fully abolished on the basis of drug addition, to further abolish the medical supplies bonus policy to promote the removal of 'to make up the doctor'.

This year, all the public in the country hospital Have to cancel the drug bonus, 'medicine to make up medicine' is about to turn the article.

But it also means that 'to fill the doctor' will be focused on the eye, the national public hospitals will also be phased out can be a separate charge of medical supplies and the difference between the rate of addition policy, medical supplies according to the actual purchase price The

'Supplies zero plus' direct impact is the hospital income, channel narrowing, the relevant compensation mechanism did not keep up, the hospital may be a policy loss.While the replacement measures, but may fall on the supplies manufacturers who, in various names The emergence of the rebate, managed mode sought after.

The report put forward: to carry out high-value medical supplies cost price survey, accurate grasp of high value of medical supplies price costs.

High value of supplies cost price survey, as well as the factory, ports, and retail prices open, if really implemented, the value of high-value supplies will tend to be transparent, manufacturers of the existing price system by the impact.

The hospital will also be able to grasp the true profits of high value supplies, a change in information asymmetry situation, bargaining negotiations with suppliers in the more advantages, bargaining space will become larger.

The report put forward: the establishment of high-value medical supplies price normalization monitoring mechanism to dynamically monitor the high value of medical supplies prices, port prices, as well as in China, the origin and neighboring countries (regions) retail prices, and the appropriate way to the community, Give full play to the role of social supervision.

As early as ten years ago, the National Development and Reform Commission to focus on the plant (mediated) into the class medical instruments The circulation of the rate of increase and the purchase and sale of price management. Even the red head files are intended to be out, but also in the industry, but the views of foreign investors, but by the foreign boycott, no below.

A few years ago, the new plant (mediated) into the medical equipment price management Interim approach has been proposed, compared to the old version of the document, the factory (port) price to the terminal sales price between the highest rate of increase, in fact, almost But later it was put on hold.

Today, the National Development and Reform Commission in the nineteenth session of the special report also made it clear that the high value of supplies to the factory, the port price dynamic monitoring, and for social exposure.

To be open in China, the origin and the surrounding retail prices, the current centralized procurement, open tender mode, in fact, has high value of the national retail price to open the public, but the origin and the surrounding price exposure and reference , Not how to see.

It seems that the NDRC has not yet died of high-value consumables.

And compared with a decade ago and a few years ago, the health care environment has been greatly different, and anti-price monopoly of medical equipment has been opened since 2013, has been shelved things, this time, may really be a reality, Come back and forth.

The report put forward: the study will be the quality difference is not large, the price level of some of the high value of medical supplies packaged into medical services, through the development of medical services charges indirect control of medical supplies price level.

Medical supplies packaged charges, in fact, is to make supplies become a cost factor, induced hospital bargain, and reduce the use of unnecessary supplies.

2012, the Development and Reform Commission to launch the price management policy, requiring as far as possible one-time medical supplies into the medical services package charges, do not allow a separate charge.However, from all over the practice point of view, are also for low-value supplies.

Development and Reform Commission proposed to the high value of supplies also implemented package charges, high value supplies manufacturers to suffer the impact.

Look at the results of the one-time charge package:

Inner Mongolia version of the price change, the appendectomy surgery costs from 270 yuan per case rose to 800 yuan per case, but after deducting 300 yuan packaging supplies, adjusted prices and the average price of 500 yuan per case just flat.

Doctors surgery costs to rise, the patient can not spend, save money from where to find? Consumables packaged charges, which is the means.

Another example is the price change in Qingdao, Shandong Province, will allow a number of additional charges to be included in the pricing costs, no longer charge.As a result, the vast majority of the price of goods within the packaging price should be lower than the 2005 version of the use Supplies the cost of some hospitals, patients with a surgery in the price of supplies from 2900 yuan down to 230 yuan.

medicine Price reform is a long-term work since the 18th century, although the reform made a breakthrough, but from the reform objectives are still a distance, the need to reform to the depth of the current and future period, to continue around the medical price reform Objectives, path and tasks to work, we should focus on the following aspects:

- Further deepen drug price reform.

In accordance with the "advancing drug price reform" requirements, continue to promote the relevant departments to continue to improve the drug procurement mechanism, the implementation of health insurance payment standards and other policies, while strengthening the drug price behavior supervision, and further improve the drug price monitoring and early warning system, focusing on inadequate competition Drug price monitoring and information dissemination work, if necessary, carry out cost price survey, and strive to build a new drug price management mechanism in accordance with the "reform and improvement of the national shortage of drug supply protection mechanism for the implementation of the views of" requirements, to develop shortages of drugs and monopoly raw materials costs Price monitoring mechanism to strengthen the shortage of drug cost investigation and antitrust investigation.To guide the local to further improve the low price of drugs policy, the establishment of inventory list dynamic adjustment mechanism, can enter and encourage low-cost drug production and supply.

- Establish a dynamic adjustment mechanism for medical service prices.

On the basis of the cancellation of the drug addition and the adjustment of the service price, the mechanism of price adjustment and the change of the income structure should be speeded up. The relevant index system should be determined and the method of establishing the dynamic adjustment mechanism of medical service price should be established step by step Pathways and specific steps to gradually rationalize the relationship between medical services parity.To guide the local strengthening of medical service price reform and health insurance payments, medical expenses control linkage, to promote medical institutions to establish effective cost restraint mechanisms and improve the quality of technical service incentives. Health service price regional coordination mechanism, improve work efficiency, maintain policy uniformity.

Accelerate the Reform of Medical Service Pricing.

On the basis of the pre-reform pilot, comprehensively promote the reform of disease charges, and gradually expand the number of diseases, and do a good job with the medical insurance according to the disease to pay the convergence, the formation of reform and together, while increasing the service unit charges, according to disease diagnosis Related to the group charge of the research work to encourage local pilot.Through the reform, and gradually establish a cost control, easy to operate, easy to regulate, a variety of ways to complement the pricing mechanism.

Strengthen the price supervision of high value medical supplies.

Has been completely abolished on the basis of drug addition, to further eliminate the medical supplies bonus policy to promote the removal of 'to make up medicine' to carry out high-value medical supplies cost price survey, accurate grasp of high value of medical supplies cost. Medical supplies price normalization monitoring mechanism, dynamic monitoring of high value of medical supplies prices, port prices, as well as in China, the origin and neighboring countries (regions) retail prices, and the appropriate way to publish the community, give full play to social supervision. Study the quality difference is not large, the price level of some of the high value of medical supplies packaged into medical services, through the development of medical services charges indirect control of medical supplies price level.

- Good experience and policy assessment.

To sum up the good, good assessment, publicity good medical price reform as an important task, timely summary of the experience can be copied to promote the practice.To establish and improve the medical price reform supervision and assessment mechanism, closely follow the implementation of local reform policies, To carry out field research, find out the actual situation around, understand the specific practices around the timely notification. Give full play to information, especially the role of large data, accurate control of medical institutions to run the reform and medical prices, cost changes, timely improvement of relevant policies. drug And medical service price reform implementation assessment, and constantly improve the policy.